GLUE News

16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity (DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate (SSR). Doximity (DOCS) priced above the range to raise...read more

Monte Rosa Therapeutics, a preclinical biotech developing small molecule protein degraders for cancer and other diseases, raised $222 million by offering 11.7 million shares at $19, the high end of the range of $17 to $19. The company offered 1.95 million more shares than anticipated. Monte Rosa uses its proprietary protein degradation platform, QuEEN, to rapidly identify protein...read more

Monte Rosa Therapeutics, a preclinical biotech developing small molecule protein degraders for cancer and other diseases, announced terms for its IPO on Monday. The Boston, MA-based company plans to raise $176 million by offering 9.8 million shares at a price range of $17 to $19. At the midpoint of the proposed range, Monte Rosa Therapeutics would command a fully diluted market...read more

Just one IPO entered public markets after the holiday weekend, but the pipeline remained active, with 14 IPOs and 10 SPACs submitting initial filings. Cross-border payment processor dLocal (DLO) priced well above the range to raise $618 million at a $6.2 billion market cap. The Uruguay-based company provides a safe and simple platform for global...read more